Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
09/2008
09/25/2008US20080234287 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
09/25/2008US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis
09/25/2008US20080234252 2-[4-(4-Chlorophenyl)-5-(methoxymethyl)-4H-1,2,4-triazol-3-yl]isoindoline; vasopressin antagonists; dysmenorrhea, Alzheimer's disease, anorexia nervosa, anxiety, anxiety disorder, asthma, atherosclerosis, autism, cardiovascular disease
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008US20080233606 Use of raman spectroscopy in enzyme activity assays
09/24/2008EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/24/2008EP1465877B1 Positive-working photoimageable bottom antireflective coating
09/24/2008CN101270087A Isoquinoline derivatives and methods of use thereof
09/24/2008CN100420674C Process for preparing phencynonate optical isomer
09/23/2008US7427693 used in flat panel displays, for lowering threshold voltage, improving heat resistance, photostability, contrast ratio and for increasing the dielectric anisotropy and switching speeds
09/18/2008WO2008111767A1 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment
09/18/2008WO2008085927A3 Methods, compositions, and kits for the treatment of pain
09/18/2008US20080227808 5-{3-[3-Bromo-5-methylsulfanyl-2-(2-pyridin-3-yl-ethoxy)-benzylamino]-propylamino}-4H-thieno[3,2-b]pyridine-7-one; anti-Clostridium difficile agents
09/18/2008US20080227784 5-chloro-N-(3-fluoro-4-morpholinophenyl)-2-hydroxybenzamide; prophylactic and/or therapeutic treatment of diseases caused by an activation of STAT6 and/or NF- kappa B
09/18/2008US20080226581 Cosmetics, drugs; transfer optical properties; fluorescence, optical brighteners
09/17/2008EP1495003B1 Fredericamycin derivatives
09/17/2008CN101268076A Diazepinoquinolines, synthesis thereof, and intermediates thereto
09/17/2008CN101265266A Sinomenine derivative, preparation method and application thereof
09/17/2008CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases
09/12/2008WO2008109007A1 Bridged phenanthridines
09/11/2008US20080221147 Method of inhibiting neurotrophin-receptor binding
09/11/2008US20080221118 Tetrahydroquinoline Derivatives
09/10/2008EP1966145A2 Fluorescent brighteners and compositions thereof, methods of preparation and uses
09/10/2008EP1966142A2 New phenanthridine derivatives as bradykinin antagonists
09/10/2008CN101263203A Multiple chromophores based on rylene
09/10/2008CN100417653C Preparation method of thienotetrahydropyridinacetic acid and salt thereof
09/10/2008CN100417646C Lappaconitine hydrobromide preparation method
09/09/2008US7423046 acetic acid (3RS,4aRS,10bRS)-6-(3,4-bis-cyclopropylmethoxyphenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-3-yl ester, phosphodiesterase inhibitor; antiinflammatory, bronchodilator agent; bronchitis, allergic bronchitis, asthma, COPD, psoriasis, eczema, osteoarthritis, rheumatoid arthritis
09/09/2008US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/04/2008WO2008106104A2 Environmentally sensitive fluorophores
09/04/2008WO2008086678A3 The medical use of levo-phencynonate as neuroprotective agent
09/04/2008US20080214827 For severe and chronic pain; 1-(1-Cyclooctyl-piperidin-4-yl)-1,3-dihydro-benzoimidazol-2-ylidene-cyanamide and 2-[2-Cyanoimino-3-(1-cyclooctyl-piperidin-4-yl)-2,3-dihydro-benzoimidazol-1-yl]-acetamide
09/04/2008US20080214820 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc.
09/04/2008US20080214576 Topoisomerase Inhibitors and Prodrugs
09/04/2008US20080214562 Chemical Compounds
09/04/2008US20080214538 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics
09/04/2008US20080214537 Bridged phenanthridines
09/04/2008US20080214536 4-((4aR,10bR)-8,9-Dimethoxy-1,2,3,4,4a,10b-hexahydro-phenanthridin-6-yl)-N-(2-methoxyethyl)-N-methyl-benzamide; phosphodiesterase 4 inhibitors; respiratory system disorders
09/03/2008EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
09/03/2008CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one
09/03/2008CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid
09/02/2008US7420079 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate
09/02/2008US7420059 HMG-CoA reductase inhibitors and method
08/2008
08/28/2008WO2008059513A3 Compounds suitable as modulators of hdl
08/28/2008WO2008033891A3 Azonafide derived tumor and cancer targeting compounds
08/28/2008US20080207689 Formamide Derivatives For The Treatment of Diseases
08/28/2008US20080207676 Crystalline forms of an 8-Azabicyclo(3.2.1)octane compound
08/28/2008US20080206885 Environmentally sensitive fluorophores
08/27/2008EP1960366A2 N-substituted indenoisoquinolines and syntheses thereof
08/27/2008EP1960365A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
08/27/2008EP1959956A2 Sinomenine derivatives and preparation and uses thereof
08/27/2008CN101252930A Isoquinoline compounds and methods of use thereof
08/27/2008CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/26/2008US7417067 mixtures of bicyclic compounds such as lubiprostone, and triglycerides; bronchodilator agents; eye drops, capsules
08/26/2008US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors
08/21/2008US20080200551 Flourene Derivative
08/21/2008US20080200460 Chemical Compounds
08/20/2008CN101248069A Androgen receptor modulators and method of treating disease using the same
08/20/2008CN101247804A Chemical compounds
08/20/2008CN101245048A Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof
08/20/2008CN100412075C Process for preparing L-ofloxacin and ofloxacin
08/20/2008CN100412062C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
08/19/2008US7414046 Gyrase inhibitors and uses thereof
08/19/2008US7414045 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
08/14/2008WO2008096739A1 Benzimidazole compound-containing composition and light-emitting device using the composition
08/14/2008WO2008007262A3 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
08/14/2008US20080194823 Crystallizing a solid from a solution of loratadine in a nitrile solvent or a hydrocarbon solvent; free of polymorphic Form II
08/14/2008US20080194587 phosphodiesterase inhibitor; drug for respiratory system disorders
08/14/2008US20080189882 Naphth(2,3-c)acridine derivative dyes; may be mixed with disperse, thiazole, isoindole, monoazo, carbazole, anthraquinone, disazo or nitro dyes; dyeing and printing hydrophobic synthetic materials such as polyester fibers and textiles for automobiles; colorfastness
08/13/2008EP1955996A1 7, 9-Substituted tetracycline compounds
08/13/2008EP1954317A2 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
08/13/2008EP1368305B1 7, 9-substituted tetracycline compounds
08/13/2008CN101243099A Metal complex
08/13/2008CN101239947A Method for preparing cryptotanshinone
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
08/12/2008US7410977 Fluorinated 4-azasteroids as androgen receptor modulators
08/12/2008US7410746 Polymerization initiator comprises a compound having only one naphthalimide structure; radial generator comprises a compound having two or more naphthalimide structures, which also functions as a crosslinking agent
08/07/2008WO2008093881A1 Method for synthesis of nitroxyl radical
08/07/2008WO2008093737A1 Amide derivative
08/07/2008WO2008093614A1 Novel hepatitis c virus inhibitor
08/07/2008US20080188663 Process for the preparation of crystalline clopidogrel hydrogen sulphate Form I
08/07/2008US20080188662 Colorant compounds
08/07/2008US20080188660 Hexarylene and Pentarylene Tetracarboxylic Acid Diimides
08/07/2008US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine
08/07/2008US20080185555 Such as 2,3:6,7-anthracenedicarboximide derivatives; air stability, solution processability; n type; organic thin film transistors, light emitting diodes and photovoltaic devices; long lasting
08/06/2008EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/06/2008EP1951252A2 Tyrosine kinase inhibitors
08/06/2008CN100408582C Homocamptoth-ecine compounds, their preparation process and use
08/06/2008CN100408576C Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
08/05/2008US7408063 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
08/05/2008US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands
08/05/2008CA2293549C Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
08/05/2008CA2293358C Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
08/05/2008CA2268450C Neurotrophin antagonist compositions
07/2008
07/31/2008WO2007062002A3 Fluorescent brighteners and compositions thereof, methods of preparation and uses
07/30/2008CN100406461C Sulphur containing heterocyclic and naphthalimides compound and use thereof
07/30/2008CN100406460C Novel derivative of camptothecine, preparing method and use
07/30/2008CN100406458C Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell
07/30/2008CN100406013C Camptothecin derivatives
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 110